# Zevia PBC: financial statements, quarterly ZVIA · NYSE · CIK 1854139 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/zvia.md) · [Financials](/companies/zvia/financials.md) · [Filings](/companies/zvia/filings.md) · [Insiders](/companies/zvia/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zvia/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [43.1](/filings/0000950170-24-122323.md) | [37.8](/filings/0000950170-24-027159.md) | [38.8](/filings/0000950170-25-065697.md) | [40.4](/filings/0000950170-25-104098.md) | [36.4](/filings/0001437749-25-033353.md) | [39.5 d](/filings/0001437749-26-005601.md) | [38.0](/filings/0001437749-26-015202.md) | [44.5](/filings/0001437749-26-025925.md) | [40.8](/filings/0001437749-25-033353.md) | [37.9 d](/filings/0001437749-26-005601.md) | [46.1](/filings/0001437749-26-015202.md) | [45.0](/filings/0001437749-26-025925.md) | | Cost of revenue | $m | [23.5](/filings/0000950170-24-122323.md) | [22.4 d](/filings/0000950170-25-027728.md) | [21.1](/filings/0000950170-25-065697.md) | [23.5](/filings/0000950170-25-104098.md) | [18.5](/filings/0001437749-25-033353.md) | [20.0 d](/filings/0001437749-26-005601.md) | [19.0](/filings/0001437749-26-015202.md) | [22.8](/filings/0001437749-26-025925.md) | [22.2](/filings/0001437749-25-033353.md) | [19.8 d](/filings/0001437749-26-005601.md) | [23.8](/filings/0001437749-26-015202.md) | [23.0](/filings/0001437749-26-025925.md) | | Gross profit | $m | [19.6](/filings/0000950170-24-122323.md) | [15.4](/filings/0000950170-24-027159.md) | [17.7](/filings/0000950170-25-065697.md) | [16.9](/filings/0000950170-25-104098.md) | [17.9](/filings/0001437749-25-033353.md) | [19.4 d](/filings/0001437749-26-005601.md) | [19.0](/filings/0001437749-26-015202.md) | [21.7](/filings/0001437749-26-025925.md) | [18.6](/filings/0001437749-25-033353.md) | [18.1 d](/filings/0001437749-26-005601.md) | [22.3](/filings/0001437749-26-015202.md) | [22.0](/filings/0001437749-26-025925.md) | | Operating income | $m | [(11.4)](/filings/0000950170-24-122323.md) | [(8.9)](/filings/0000950170-24-027159.md) | [(7.3)](/filings/0000950170-25-065697.md) | [(7.1)](/filings/0000950170-25-104098.md) | [(3.0)](/filings/0001437749-25-033353.md) | [(6.3) d](/filings/0001437749-26-005601.md) | [(6.4)](/filings/0001437749-26-015202.md) | [(1.0)](/filings/0001437749-26-025925.md) | [(2.9)](/filings/0001437749-25-033353.md) | [(1.5) d](/filings/0001437749-26-005601.md) | [(2.4)](/filings/0001437749-26-015202.md) | [(2.9)](/filings/0001437749-26-025925.md) | | Income tax | $m | [(0.0)](/filings/0000950170-24-122323.md) | [0.0 d](/filings/0000950170-25-027728.md) | [0.0](/filings/0000950170-25-065697.md) | [0.0](/filings/0000950170-25-104098.md) | [(0.0)](/filings/0001437749-25-033353.md) | [0.0 d](/filings/0001437749-26-005601.md) | [0.0](/filings/0001437749-26-015202.md) | [0.0](/filings/0001437749-26-025925.md) | [(0.0)](/filings/0001437749-25-033353.md) | [0.0 d](/filings/0001437749-26-005601.md) | [0.0](/filings/0001437749-26-015202.md) | [0.0](/filings/0001437749-26-025925.md) | | Net income | $m | [(11.3)](/filings/0000950170-24-027159.md) | [(9.2)](/filings/0000950170-24-027159.md) | [(7.2)](/filings/0001437749-25-033353.md) | [(7.0)](/filings/0001437749-25-033353.md) | [(2.5)](/filings/0001437749-25-033353.md) | [(5.8) d](/filings/0001437749-26-005601.md) | [(5.2)](/filings/0001437749-26-015202.md) | [(0.7)](/filings/0001437749-26-025925.md) | [(2.7)](/filings/0001437749-25-033353.md) | [(1.3) d](/filings/0001437749-26-005601.md) | [(2.3)](/filings/0001437749-26-015202.md) | [(2.8)](/filings/0001437749-26-025925.md) | | Diluted EPS | $ per share | [(0.16)](/filings/0000950170-24-122323.md) | [(0.14)](/filings/0000950170-24-027159.md) | [(0.10)](/filings/0000950170-25-065697.md) | [(0.10)](/filings/0000950170-25-104098.md) | [(0.04)](/filings/0001437749-25-033353.md) | not reported | [(0.08)](/filings/0001437749-26-015202.md) | [(0.01)](/filings/0001437749-26-025925.md) | [(0.04)](/filings/0001437749-25-033353.md) | not reported | [(0.03)](/filings/0001437749-26-015202.md) | [(0.04)](/filings/0001437749-26-025925.md) | | Basic EPS | $ per share | [(0.16)](/filings/0000950170-24-122323.md) | [(0.14)](/filings/0000950170-24-027159.md) | [(0.10)](/filings/0000950170-25-065697.md) | [(0.10)](/filings/0000950170-25-104098.md) | [(0.04)](/filings/0001437749-25-033353.md) | not reported | [(0.08)](/filings/0001437749-26-015202.md) | [(0.01)](/filings/0001437749-26-025925.md) | [(0.04)](/filings/0001437749-25-033353.md) | not reported | [(0.03)](/filings/0001437749-26-015202.md) | [(0.04)](/filings/0001437749-26-025925.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [38.5](/filings/0000950170-23-060295.md) | [32.0](/filings/0000950170-25-027728.md) | [28.7](/filings/0000950170-24-055741.md) | [28.9](/filings/0000950170-24-092727.md) | [32.7](/filings/0000950170-24-122323.md) | [30.7](/filings/0001437749-26-005601.md) | [27.7](/filings/0000950170-25-065697.md) | [26.3](/filings/0000950170-25-104098.md) | [26.0](/filings/0001437749-25-033353.md) | [25.4](/filings/0001437749-26-025925.md) | [26.6](/filings/0001437749-26-015202.md) | [28.5](/filings/0001437749-26-025925.md) | | Current assets | $m | [107](/filings/0000950170-23-060295.md) | [82.7](/filings/0000950170-25-027728.md) | [77.4](/filings/0000950170-24-055741.md) | [65.5](/filings/0000950170-24-092727.md) | [66.1](/filings/0000950170-24-122323.md) | [61.9](/filings/0001437749-26-005601.md) | [56.3](/filings/0000950170-25-065697.md) | [56.9](/filings/0000950170-25-104098.md) | [54.5](/filings/0001437749-25-033353.md) | [58.2](/filings/0001437749-26-025925.md) | [52.7](/filings/0001437749-26-015202.md) | [58.6](/filings/0001437749-26-025925.md) | | Total assets | $m | [116](/filings/0000950170-23-060295.md) | [90.9](/filings/0000950170-25-027728.md) | [85.1](/filings/0000950170-24-055741.md) | [72.8](/filings/0000950170-24-092727.md) | [72.9](/filings/0000950170-24-122323.md) | [68.0](/filings/0001437749-26-005601.md) | [62.0](/filings/0000950170-25-065697.md) | [62.5](/filings/0000950170-25-104098.md) | [60.0](/filings/0001437749-25-033353.md) | [63.6](/filings/0001437749-26-025925.md) | [57.9](/filings/0001437749-26-015202.md) | [64.2](/filings/0001437749-26-025925.md) | | Current liabilities | $m | [45.6](/filings/0000950170-23-060295.md) | [27.7](/filings/0000950170-25-027728.md) | [27.8](/filings/0000950170-24-055741.md) | [21.2](/filings/0000950170-24-092727.md) | [23.2](/filings/0000950170-24-122323.md) | [24.2](/filings/0001437749-26-005601.md) | [24.0](/filings/0000950170-25-065697.md) | [24.3](/filings/0000950170-25-104098.md) | [24.0](/filings/0001437749-25-033353.md) | [28.0](/filings/0001437749-26-025925.md) | [23.8](/filings/0001437749-26-015202.md) | [30.9](/filings/0001437749-26-025925.md) | | Total liabilities | $m | [47.1](/filings/0000950170-23-060295.md) | [29.1](/filings/0000950170-25-027728.md) | [29.0](/filings/0000950170-24-055741.md) | [22.3](/filings/0000950170-24-092727.md) | [24.1](/filings/0000950170-24-122323.md) | [25.0](/filings/0001437749-26-005601.md) | [24.7](/filings/0000950170-25-065697.md) | [24.8](/filings/0000950170-25-104098.md) | [24.2](/filings/0001437749-25-033353.md) | [28.0](/filings/0001437749-26-025925.md) | [23.8](/filings/0001437749-26-015202.md) | [30.9](/filings/0001437749-26-025925.md) | | Shareholders' equity | $m | [101](/filings/0000950170-23-060295.md) | [89.9](/filings/0000950170-25-027728.md) | [80.3](/filings/0000950170-24-055741.md) | [75.0](/filings/0000950170-24-092727.md) | [72.5](/filings/0000950170-24-122323.md) | [64.9](/filings/0001437749-26-005601.md) | [53.7](/filings/0000950170-25-065697.md) | [53.0](/filings/0000950170-25-104098.md) | [51.3](/filings/0001437749-25-033353.md) | [51.0](/filings/0001437749-26-025925.md) | [44.9](/filings/0001437749-26-015202.md) | [44.1](/filings/0001437749-26-025925.md) | - Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(10.7) d](/filings/0000950170-24-122323.md) | [(6.6) d](/filings/0000950170-25-027728.md) | [(3.2)](/filings/0000950170-25-065697.md) | [0.3 d](/filings/0000950170-25-104098.md) | [3.9 d](/filings/0001437749-25-033353.md) | [(2.0) d](/filings/0001437749-26-005601.md) | [(2.9)](/filings/0001437749-26-015202.md) | [(1.4) d](/filings/0001437749-26-025925.md) | [0.1 d](/filings/0001437749-25-033353.md) | [(0.5) d](/filings/0001437749-26-005601.md) | [1.6](/filings/0001437749-26-015202.md) | [2.3 d](/filings/0001437749-26-025925.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-005601.md) | [0.0](/filings/0001437749-26-015202.md) | [0.0 d](/filings/0001437749-26-025925.md) | [0.2 d](/filings/0001437749-25-033353.md) | [0.1 d](/filings/0001437749-26-005601.md) | [0.3](/filings/0001437749-26-015202.md) | [0.1 d](/filings/0001437749-26-025925.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: not reported ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [72.3](/filings/0000950170-24-055741.md) | [50.1](/filings/0000950170-24-092727.md) | [50.8](/filings/0000950170-24-122323.md) | [52.2](/filings/0000950170-24-027159.md) | [55.9](/filings/0000950170-25-065697.md) | [58.7](/filings/0000950170-25-104098.md) | [59.5](/filings/0001437749-25-033353.md) | [76.5](/filings/0001437749-26-015202.md) | [66.3](/filings/0001437749-26-025925.md) | [67.3](/filings/0001437749-25-033353.md) | [68.2](/filings/0001437749-26-015202.md) | [71.8](/filings/0001437749-26-025925.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.